PharVision Advisers’s Hecla Mining HL Stock Holding History

PharVision Advisers’s Portfolio HL Stock Details HL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,789	Closed	-$215K	–	824
2025 Q3	$215K	Buy	+17,789	New	+$143K	0.12%	453

Other funds holding HL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's HL Position: Q4 2025 in Review

PharVision Advisers sold out of Hecla Mining (HL) in Q4 2025, closing a stake of 17,789 shares — an estimated $215K sold.

PharVision Advisers first reported a position in HL in Q3 2025 and held it in 1 quarter. The position peaked at $215K in Q3 2025. 525 funds tracked by Wall St. Rank hold HL as of Q4 2025.

PharVision Advisers reported no remaining Hecla Mining position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 17,789 Hecla Mining shares in Q4 2025, an estimated $215K.
PharVision Advisers first reported a position in Hecla Mining in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Hecla Mining position peaked at $215K in Q3 2025.
525 funds tracked by Wall St. Rank held Hecla Mining as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.